W7J-12994-13721
4 vaccinations
5 coded responses
53 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XF7-21352-53022
Child or adolescent in my care · Male · 2022-07-23
MX6-23614-71604
Child or adolescent in my care · Female · 2022-10-11
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — day 7, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-07-20
- 2021-10-19
-
2021-11-12
Dose 3 — Pfizer-BioNTech
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
- 2022-05-13
-
2022-10-19
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-19
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-25
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
- 2022-11-30
- 2023-01-18
- 2023-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-19 | Pfizer-BioNTech | Flu |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Bruise at injection site
Systemic reaction (other): Bruise at injection site
Release 7 — day 7, dose 1
Systemic reaction (other): Bruise at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release